By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


European Medicines Agency (EMA) 

7 Westferry Circus
Canary Wharf
London    E14 4HB  United Kingdom
Phone: 44-0-20-7523-7600 Fax: n/a



Company News
TetraPhase (TTPH) Announces Submission And Validation Of IV Eravacycline Marketing Authorization Application By EMA 8/17/2017 10:11:22 AM
Akcea Therapeutics And Ionis Pharma (IONS) Announce Submission Of Marketing Authorization Application For Volanesorsen To The EMA 7/27/2017 6:35:00 AM
Tocagen Receives EMA Priority Medicines (PRIME) Designation For Toca 511 In High Grade Glioma 7/24/2017 7:42:28 AM
Vanda (VNDA) Receives Negative Opinion For Marketing Authorization From The EMA On Fanaptum For The Treatment Of Schizophrenia 7/21/2017 7:28:36 AM
Merck KGaA (MKGAF.PK) Release: EMA's CHMP Issues Positive Opinion For Avelumab For The Treatment Of Metastatic Merkel Cell Carcinoma 7/21/2017 7:25:12 AM
EMA's CHMP Recommends Approval For Merck & Co. (MRK)’s KEYTRUDA (Pembrolizumab) For The Treatment Of Certain Patients With Locally Advanced Or Metastatic Urothelial Carcinoma, A Type Of Bladder Cancer 7/21/2017 7:15:26 AM
Bay Area Nektar (NKTR)' Comeback is Stalled as the EMA Rejects Breast Cancer Drug 7/21/2017 6:30:36 AM
Evolus Announces EMA Acceptance For Review Of The Marketing Authorization Application For DWP-450 Neuromodulator 7/20/2017 10:12:14 AM
CTI BioPharma Announces EMA Validation Of Pacritinib Marketing Authorization Application For Patients With Myelofibrosis Who Have Thrombocytopenia 7/14/2017 6:31:46 AM
EMA Validates Gilead (GILD)’s Marketing Application For Fixed-Dose Combination Of Bictegravir, Emtricitabine And Tenofovir Alafenamide For Treatment Of HIV 7/13/2017 6:34:39 AM